Effect of splenectomy and mono- or combination therapy with rapamycin, the morpholinoethyl ester of mycophenolic acid and deoxyspergualin on cardiac xenograft survival.
Wang
J
J
Department of Cardiovascular Surgery, Stanford University School of Medicine, California 94305-5247.
Morris
R E
RE
D000818:Animals; D003131:Combined Modality Therapy; D006224:Cricetinae; D004359:Drug Therapy, Combination; D006084:Graft Rejection; D006085:Graft Survival; D006146:Guanidines / Q000627:therapeutic use*; D016027:Heart Transplantation / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008647:Mesocricetus; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011090:Polyenes / Q000627:therapeutic use*; D051381:Rats; D011917:Rats, Inbred Lew; D020123:Sirolimus; D013156:Splenectomy; D014183:Transplantation, Heterologous / Q000276:immunology*
D006146:Guanidines; D007166:Immunosuppressive Agents; D011090:Polyenes; D009173:Mycophenolic Acid; C037258:gusperimus; D020123:Sirolimus